This annual meeting will welcome abstract submissions on a wide range of topics in biliary science from overseas. In addition, you will also submit the abstracts for the two international video sessions. We look forward to your participation.

Abstract Submission Period

February 3 (Tuesday) – March 31 (Tuesday) at 12:00PM (JST)

Session Theme

• Video Session 1
  Minimally Invasive Surgery for Biliary Diseases

  MIS for biliary tract diseases has steadily advanced and is now widely adopted. In Japan, laparoscopic procedures for gallstones, cholecystitis, CBD stones, Kasai portoenterostomy, extrahepatic bile duct resection for pancreaticobiliary maljunction, gallbladder bed resection for gallbladder cancer, and pancreaticoduodenectomy for distal bile duct cancer are currently performed under national health insurance coverage. With the introduction of robot-assisted surgery, further expansion of indications and surgical procedures is anticipated in the near future. In this session, based on video presentations by experts, including international speakers, we will discuss the feasibility of a wide variety of procedures, including those not yet covered by the Japanese insurance system.

• Video Session 3
  New Modalities and Devices in Cholangioscopic Diagnosis and Treatment

  Biliary endoscopic diagnosis and therapy has evolved steadily, and it is fair to say that this progress has been driven by advances in modalities and devices. Innovation continues, and further ingenuity and development will be essential for the next stage of progress. We sincerely welcome video presentations on any topic in biliary endoscopy, particularly those featuring new modalities, novel devices, or creative applications that may shape future practice. Submissions may range from clinical studies to early exploratory work, including pilot experiences, small case series, or experimental approaches, provided that the rationale and key messages are clear. Let’s share fresh ideas, spark lively discussion, and create new knowledge together.

General Abstract (Oral / Poster)

The 62nd Annual Meeting of the Japan Biliary Association accepts abstracts for General Abstract. Please select the abstract category from the list below. Please understand that the congress president will make a final decision on the presentation style, presentation session, as well as acceptance/rejection.

Category 1 (By Body Region)

Category 2 (Subcategory)

Submission Guidelines

Please submit abstracts online using the official Abstract Submission Form. Abstracts submitted via email will not be accepted.

• Language for abstract, presentation and presentation slides: English
• Number of words:

  -

  Abstract title must not exceed 180 characters, including spaces.

  -

  The entire abstract (total characters of author names, affiliations, title, and body) must not exceed:

  • Without figures/tables: 1,792 characters, including spaces
  • With figures/tables: 1,200 characters, including spaces

  -

  The maximum size for figures and tables is 330 pixels in height and 500 pixels in width.

  A single file should be submitted in JPEG or PNG format.
• The number of co-authos is limited to 2 persons per abstract for Video Session. And General Abstract (Oral / Poster) limited to 14 persons per abstract.

Conflict of Interest

In accordance with the Japan Biliary Association Conflict of Interest Management Guidelines all speakers are required to disclose their conflicts of interest for three years prior to abstract submission.

Abstract Submission

Please send us your Abstract Format and COI disclosure form.

Notification of Abstract Acceptance

Notification of acceptance or rejection will be announced by email at the end of June 2026 to the email address you registered when submitting your abstract. The detailed information about presentation schedule, such as date and place, is going to be mentioned in the notification of acceptance.

For Inquiries about Abstract Submission

c/o Japan Convention Services, Inc.
E-mail: endai-62jba[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )